Health and Healthcare
5864 Articles
Zafgen has announced positive efficacy results from its Phase 2b ZAF-203 clinical trial evaluating beloranib, a MetAP2 inhibitor, in the…
Regulus Therapeutics has reported positive interim results from its Phase 2 study for the treatment of hepatitis C virus (HCV)…
Ocular Therapeutix led the bulls in early trading indications on Thursday, following a positive meeting with the FDA.
Express Scripts Holding Co. (NASDAQ: ESRX) reported fourth quarter financial results after the markets closed on Tuesday. The company had…
Community Health Systems spooked investors badly enough that all hospital stocks were running in the red on Tuesday.
Express Scripts is set to report its fourth-quarter financial results after the markets close on Tuesday.
In 2016 alone, this stock has taken a beating, and unless this company can turn itself around in the near…
Pfizer has announced that it had settled outstanding claims for a total of more than $784 million related to calculated…
Baxalta is scheduled to report fourth-quarter and full-year results before markets open on Tuesday.
Here are six biotech and pharma stocks that analysts are telling their firm's clients to buy now for solid upside…
These biotech companies 24/7 Wall St. has picked stood out from the rest with big moves over the course of…
Clovis Oncology traded down on Friday after the company said the FDA scheduled the New Drug Application for rociletinib for…
Incyte reported better-than-expectged fourth-quarter financial results after the markets closed on Wednesday.
CTI BioPharma has practically become a penny stock overnight following an update from its Investigational New Drug (IND) application for…
Proteostasis Therapeutics expects to price less than 4 million shares in the range of $12 to $14 apiece in an…
Our top personal finance-related articles today. Your wallet will thank you later.